IACCARINO, Guido
 Distribuzione geografica
Continente #
NA - Nord America 11.715
AS - Asia 8.700
EU - Europa 2.859
SA - Sud America 396
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 4
Totale 23.736
Nazione #
US - Stati Uniti d'America 11.663
HK - Hong Kong 6.400
CN - Cina 734
SG - Singapore 714
UA - Ucraina 700
IT - Italia 693
RU - Federazione Russa 376
DE - Germania 362
BR - Brasile 357
VN - Vietnam 351
IE - Irlanda 226
TR - Turchia 219
FI - Finlandia 179
SE - Svezia 170
KR - Corea 165
GB - Regno Unito 49
IN - India 33
CA - Canada 24
NL - Olanda 21
EU - Europa 20
MX - Messico 20
AR - Argentina 18
BD - Bangladesh 18
PL - Polonia 17
AT - Austria 14
FR - Francia 14
JP - Giappone 14
IQ - Iraq 12
CZ - Repubblica Ceca 9
ZA - Sudafrica 8
EC - Ecuador 7
PK - Pakistan 7
VE - Venezuela 6
ES - Italia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
JO - Giordania 4
KE - Kenya 4
MA - Marocco 4
UZ - Uzbekistan 4
AU - Australia 3
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
BH - Bahrain 3
LT - Lituania 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
SN - Senegal 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GH - Ghana 2
GY - Guiana 2
IL - Israele 2
JM - Giamaica 2
LU - Lussemburgo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BJ - Benin 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
MG - Madagascar 1
MK - Macedonia 1
NE - Niger 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 23.736
Città #
Hong Kong 6.394
Ann Arbor 2.883
Wilmington 2.392
Jacksonville 882
Woodbridge 854
Chandler 846
Princeton 691
Houston 566
Dallas 385
Dong Ket 307
Singapore 277
Dublin 225
Izmir 205
Ashburn 188
Nanjing 159
Andover 158
Boardman 157
Pellezzano 138
Mestre 135
Moscow 123
Dearborn 97
Beijing 96
Munich 88
Salerno 86
Düsseldorf 80
Fairfield 71
Changsha 54
Los Angeles 54
Shenyang 53
Hebei 44
Falls Church 42
Nanchang 42
Jiaxing 32
Saint Petersburg 32
São Paulo 32
Napoli 31
Norwalk 31
New York 30
Turku 25
San Francisco 24
Tianjin 24
Venezia 23
Rome 22
San Diego 22
Jinan 18
Nuremberg 18
The Dalles 18
Grevenbroich 17
Milan 17
Redwood City 17
Columbus 16
Naples 16
Cambridge 15
Guangzhou 15
Ho Chi Minh City 15
Rio de Janeiro 15
Brooklyn 14
Washington 14
London 13
Pune 13
Santa Clara 13
Tokyo 13
Warsaw 12
Hanoi 11
Lappeenranta 11
Shanghai 11
Charlotte 10
Council Bluffs 10
Montreal 10
Seattle 10
Amsterdam 9
Phoenix 9
Stockholm 9
Atlanta 8
Buffalo 8
Salvador 8
Tappahannock 8
Bari 7
Belo Horizonte 7
Boston 7
Denver 7
Helsinki 7
Johannesburg 7
Manchester 7
Baghdad 6
Brno 6
Haikou 6
Lanzhou 6
Mexico City 6
Chicago 5
Genoa 5
Indiana 5
Nettuno 5
Turin 5
Vienna 5
Assago 4
Brasília 4
Contagem 4
Des Moines 4
Florence 4
Totale 19.650
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 844
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 833
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 542
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 493
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 481
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 393
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 388
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 289
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 258
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 257
Adrenergic signaling in heart failure and cardiovascular aging 253
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 248
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 245
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 238
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 230
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 228
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 221
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 215
Serum uric acid and left ventricular mass in essential hypertension 214
Thyroid function predicts increased cardiovascular risk 210
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 190
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 187
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 179
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 176
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 175
Characterization of a selective CaMKII peptide inhibitor 174
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 170
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 169
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 169
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 166
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 163
AKT participates in endothelial dysfunction in hypertension. 159
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 159
Targeting myocardial remodelling to develop novel therapies for heart failure 156
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 156
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 152
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 144
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 140
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 137
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 136
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 133
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 132
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 131
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 130
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 129
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 129
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 129
Active and Healthy Ageing and Independent Living 129
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 127
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 127
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 126
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 124
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 124
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 122
Active and Healthy Ageing and Independent Living 2016 121
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 120
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 119
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 119
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 118
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 118
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 118
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 118
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 117
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 116
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 116
Insufficient control of blood pressure and incident diabetes. 114
External support modulates G protein expression and receptor coupling in experimental vein grafts. 113
G Protein-Coupled Receptor Kinases and Hypertension 113
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. 112
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 112
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 111
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 110
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 109
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 109
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 108
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 108
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 108
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 108
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 106
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. 105
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 105
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 105
Atrial fibrillation and microRNAs 105
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. 104
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 104
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 103
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 103
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 103
Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. 102
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor 102
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 102
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit. 101
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 100
GRK2 at the control shaft of cellular metabolism 100
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 100
CaMK4 Gene Deletion Induces Hypertension 100
Good at Heart: Preserving Cardiac Metabolism during aging 100
Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy 100
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 100
Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. 99
Totale 17.113
Categoria #
all - tutte 70.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.212 0 0 162 1 154 49 167 17 164 5 148 345
2021/20221.236 3 0 5 11 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/20267.399 1.316 3.436 2.647 0 0 0 0 0 0 0 0 0
Totale 24.181